MEG3 imprinted gene contribution in tumorigenesis
- PMID: 21400503
- DOI: 10.1002/ijc.26052
MEG3 imprinted gene contribution in tumorigenesis
Abstract
Maternally expressed gene 3 (MEG3) is a maternally expressed imprinted gene representing a large noncoding RNA in which microRNAs (miRNAs) and small nucleolar RNAs are also hosted. It is capable of interacting with cyclic AMP, p53, murine double minute 2 (MDM2) and growth differentiation factor 15 (GDF15) playing a role in cell proliferation control. MEG3 expression is under epigenetic control, and aberrant CpG methylation has been observed in several types of cancer. Moreover, gene copy number loss has been reported as additional mechanism associated with tumorigenesis. MEG3 deletion seems to upregulate the paternally expressed genes and on the other hand downregulate the expression of downstream maternally expressed genes and tumor suppressor miRNAs, although there are conflicting data on the topic. MEG3 could represent a tumor suppressor gene located in chromosome 14q32 and its association with tumorigenesis is growing every day.
Copyright © 2011 UICC.
Similar articles
-
Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.Cancer Res. 2010 Mar 15;70(6):2350-8. doi: 10.1158/0008-5472.CAN-09-3885. Epub 2010 Feb 23. Cancer Res. 2010. PMID: 20179190 Free PMC article.
-
Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3.Genes Cells. 2000 Dec;5(12):1029-37. doi: 10.1046/j.1365-2443.2000.00390.x. Genes Cells. 2000. PMID: 11168589
-
Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.Mol Carcinog. 2017 Mar;56(3):1041-1054. doi: 10.1002/mc.22569. Epub 2016 Oct 20. Mol Carcinog. 2017. PMID: 27597634
-
MEG3 noncoding RNA: a tumor suppressor.J Mol Endocrinol. 2012 Apr 2;48(3):R45-53. doi: 10.1530/JME-12-0008. Print 2012 Jun. J Mol Endocrinol. 2012. PMID: 22393162 Free PMC article. Review.
-
Potential applications of MEG3 in cancer diagnosis and prognosis.Oncotarget. 2017 Aug 4;8(42):73282-73295. doi: 10.18632/oncotarget.19931. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069869 Free PMC article. Review.
Cited by
-
Silencing of MEG3 attenuated the role of lipopolysaccharides by modulating the miR-93-5p/PTEN pathway in Leydig cells.Reprod Biol Endocrinol. 2021 Feb 27;19(1):33. doi: 10.1186/s12958-021-00712-5. Reprod Biol Endocrinol. 2021. PMID: 33639974 Free PMC article.
-
Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.Tumour Biol. 2015 Jun;36(6):4851-9. doi: 10.1007/s13277-015-3139-2. Epub 2015 Feb 1. Tumour Biol. 2015. PMID: 25636452
-
Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.Stem Cell Res Ther. 2015 Jan 5;6(1):1. doi: 10.1186/scrt535. Stem Cell Res Ther. 2015. PMID: 25559585 Free PMC article.
-
Long noncoding RNAs in head and neck cancer.Oncotarget. 2017 Feb 7;8(6):10726-10740. doi: 10.18632/oncotarget.12960. Oncotarget. 2017. PMID: 27802187 Free PMC article. Review.
-
Regulation of lncRNA and Its Role in Cancer Metastasis.Oncol Res. 2016;23(5):205-17. doi: 10.3727/096504016X14549667334007. Oncol Res. 2016. PMID: 27098144 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous